raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:453533

Polyendocrine-polyneuropathy syndrome

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Childhood
Status
active

A rare genetic disease characterized by childhood onset of multiple endocrine manifestations in combination with central and peripheral nervous system abnormalities. Reported signs and symptoms include postnatal growth retardation, moderate intellectual disability, hypogonadotropic hypogonadism, insulin-dependent diabetes mellitus, central hypothyroidism, demyelinating sensorimotor polyneuropathy, and cerebellar and pyramidal signs. Progressive hearing loss and a hypoplastic pituitary gland have also been described. Brain imaging shows moderate white matter abnormalities.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enPolyendocrine-polyneuropathy syndrome
frSyndrome de polyendocrinopathie-polyneuropathie
dePolyendokrine Polyneuropathie-Syndrom
esSíndrome poliendocrino-polineuropatía
itSindrome poliendocrina-polineuropatia
nlPolyendocrinopathie - polyneuropathie-syndroom
ptSíndrome de polineuropatia poliendócrina
plZespół poliendokrynopatii i polineuropatii
csPolyendokrinní-polyneuropatický syndrom
ukСиндром поліендокринно-полінейропатії
zh多内分泌腺-多神经累及综合征
trPoliendokrin-polinöropati sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM616113Evalidated
ICD-10E34.8NTBTattributedvalidated
MONDO0014497Evalidated
UMLSC4015261Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (5):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
DMXL2Disease-causing germline mutation(s) inAssessedHGNC:2938ENSG0000010409361218615q21.2Dmx like 225248098[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families3 casesWorldwideCase(s)Validated25248098[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_25248098[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

23 annotations · validated 2019-12-10
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0007256Abnormal pyramidal sign
HP:0001596Alopecia
HP:0001251Ataxia
HP:0030341Decreased circulating follicle stimulating hormone concentration
HP:0030344Decreased circulating luteinizing hormone level
HP:0040171Decreased serum testosterone concentration
HP:0008734Decreased testicular size
HP:0007108Demyelinating peripheral neuropathy
HP:0001260Dysarthria
HP:0001332Dystonia
HP:0100287EMG: slow motor conduction
HP:0001943Hypoglycemia
HP:0000044Hypogonadotropic hypogonadism
HP:0002342Intellectual disability, moderate
HP:0001761Pes cavus
HP:0008897Postnatal growth retardation
HP:0001730Progressive hearing impairment
HP:0008994Proximal muscle weakness in lower limbs
HP:0005978Type II diabetes mellitus
Occasional (29-5%)
HP:0010627Anterior pituitary hypoplasia
HP:0011787Central hypothyroidism
HP:0001321Cerebellar hypoplasia
HP:0040216Hypoinsulinemia

Annotation source: 25248098[PMID]

7

Sources for this card